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ABSTRACT Sjögren’s syndrome (SS) is a systemic autoimmune disease. A 
large percentage of patients with SS suffer from dry skin, the cause and 
pathogenesis of which in this group of patients remains obscure. The aim 
of the present study was to investigate skin barrier function in patients 
with SS. Measurements of transepidermal water loss (TEWL) and hydration 
of stratum corneum (corneometry, CM) were performed in 30 female pa-
tients with SS (17 with primary SS and 13 with secondary SS), 20 patients 
with atopic dermatitis (AD) and 14 healthy controls. There were no statisti-
cally significant differences in TEWL values between the three investigated 
groups, while CM values were significantly decreased in patients with AD 
when compared with patients with SS and the healthy controls. Based on 
the obtained results, skin barrier function and hydration in patients with 
SS showed no functional alterations. 
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INTRODUCTION
Sjögren’s syndrome (SS) is a systemic chronic au-
toimmune disorder, which can manifest alone as pri-
mary (p)SS or in association with other autoimmune 
rheumatic disease as secondary (s)SS (1). It is charac-
terized by exocrine gland dysfunction and lympho-
cytic infiltrations. The dominant symptoms, namely 
xerophthalmia and xerostomia, result from epithelitis 
which causes glandular destruction. Clinical experi-
ence has shown that the majority of patients with 
SS also suffer from dry skin and xerosis (2). The cause 
of subjective symptoms, such as dryness sensation 
or xerosis, clinically manifested as roughness, loss 
of elasticity, scaling, cracks, and fissures, is unclear. 
The study by Bernacchi et al. showed that cutaneous 
xerosis in primary patients with (p)SS, unlike xeroph-
talmia and xerostomia, is not a result of a chronic 
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lymphocytic infiltrate of the eccrine or sebaceous 
glands, but is related to peculiar biochemical altera-
tions of the epidermis, similar to those seen in elderly 
patients (3). 
To address the issue of dry skin sensation in pa-
tients with SS with differentiation between the pri-
mary and secondary variants of the syndrome, we 
assessed skin functional parameters such as transepi-
dermal water loss (TEWL) and stratum corneum hy-
dration in these groups of patients.
METHODS
We enrolled 30 consecutive female patients with 
SS to this pilot study (mean age ± Standard Devia-
tion 50.4±13.5, 17 with (p)SS and 13 with secondary 
(s)SS), all of whom fulfilled the 2002 American-Eu-
ropean Consensus Group classification criteria (1). 
Fourteen age- and sex-matched healthy subjects 
formed the control group (mean age 50.4±10.1), and 
20 patients with atopic dermatitis (AD) formed the 
disease control (mean age 35±12.3). The protocol of 
this study was approved by the Institutional Review 
Board at Poznan University of Medical Sciences (num-
ber 211/13) and informed consent was obtained from 
all investigated subjects before any study procedure 
was carried out. 
The workup comprised the complete medical 
history and thorough physical examination, which 
included Schirmer’s test and fluorescein tear break-
up time (TBUT) test. To assess xerostomia, all patients 
also completed the visual analogue scale (VAS). Two 
noninvasive methods were performed to determine 
the skin barrier functions, namely the measurement 
of TEWL and hydration of stratum corneum (corne-
ometry, CM). TEWL was determined using Tewameter 
TM 300 (Courage-Khazaka, Germany) according to 
the guidelines of the standardization group of the 
European Society of Contact Dermatitis (at least 20 
measurements given as a mean value and expressed 
in SI units (g/m2/h) were carried out, normal range: 
0-25 g/m2/h) (4). Corneometry was performed with 
the use of Corneometer CM 825 (Courage-Khazaka, 
Germany), the main principle of which is based on 
the fact that the dielectric constant of water is 81 but 
is lower for dry skin. A normal value of stratum cor-
neum hydration was accepted as higher than 40 U. 
Five measurements given as a mean value in arbitrary 
units (range: 0-130) were determined in accordance 
with guidelines (5). Both parameters were analyzed 
within the flexural area of the right extremity – fore-
arm, and in patients with AD the area was without in-
flammatory lesions. All skin studies were performed 
by the same trained dermatologist in the same room 
conditions, after 15-20 minutes of acclimatization. 
The patients did not use an emollient 24 h before the 
test. All patients were also asked about the feeling of 
dry skin in a form of yes/no question. Blood samples 
from patients were collected at the time of clinical ex-
amination on fasting conditions. Routine laboratory 
tests included measurement of the erythrocyte sedi-
mentation rate (ESR, Westergren method) and detec-
tion of antinuclear antibodies (ANA) by indirect im-
munofluorescence on HEp-20-10 cells (Euroimmun, 
Germany) and their specification using blot type test 
(Euroimmun, Germany). All samples were stored at -
20 °C before estimations were made.
Table 1. Clinical and laboratory characteristics of patients with Sjögren’s syndrome (n=30)
Primary Sjögren’s syndrome 
patients (n=17)
Secondary Sjögren’s syndrome 
patients (n=13)
Age 48.2±14.9 53.6±10.6
Disease duration (years) 5 (8) 2 (4)
Antinuclear antibodies (%) 15 (88.2) 9 (69.2)
anti-Ro/SSA antibodies (%) 13 (76.5) 5 (38.5)
anti-La/SSB antibodies (%) 8 (61.5) 3 (23.1)
Xerostomia (visual analogue scale, mm) 56 (54.0) 14 (49.5)
Rheumatoid arthritis (%) 0 9 (69.2)
Systemic lupus erythematosus (%) 0 3 (23.1)
Mixed connective tissue disease (%) 0 1 (7.7)
Erythrocyte sedimentation rate (mm/h) 19 (37.0) 20.5 (14.5)
Therapy with low-dose methylprednisolone (%) 3 (17.6) 6 (46.2)
Therapy with chlorochine (%) 0 3 (23.1)
Therapy with methotrexate (%) 0 5 (38.5)
Therapy with azathioprine (%) 1 (5.9) 1 (7.7)
Current smokers (%) 2 (11.8) 1 (7.7)
Data presented as the median (interquartile range), mean ± standard deviation or as n (%).
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Calculations were carried out with Microsoft Excel 
2010 and STATISTICA version 10 software (StatSoft 
Inc.). Patient demographic data were analyzed using 
descriptive statistics. Contiguous data were tested for 
normal distribution using the Kolmogorov–Smirnov 
test. In case of normally distributed data, results were 
presented as mean ± Standard Deviation (SD), where-
as non-normally distributed data were expressed as 
median (interquartile range; IQR). Depending on the 
number of analyzed groups, the differences between 
them were tested using the Mann-Whitney U test or 
analysis of variance (ANOVA) by ranks followed by 
post-hoc multiple comparisons of the mean ranks. 
Correlations between variables within the group 
were analyzed using Spearman’s rank-order correla-
tion coefficient (r). The differences were considered to 
be statistically significant at P<0.05.
RESULTS
The characteristics of the SS patient group at the 
time of examination is shown in Table 1.
In the pSS subgroup, 12 (70.6%) patients com-
plained of dry skin, and 10 (76.9%) in the sSS sub-
group. Out of 17 patients with pSS, only 3 (17.6%), 
and in the sSS subgroup only 1 (7.7%), patient had 
TEWL values above the normal range. The stratum 
corneum hydration was abnormal in 7 (41.2%) pa-
tients with pSS and in 4 (30.8%) with sSS. There were 
no statistically significant differences in TEWL values 
between all investigated groups, but CM results were 
significantly decreased in patients with AD when 
compared with SS subjects and the healthy controls 
(Figure 1). The results of TEWL and CM are summa-
rized in Table 2.
In pSS, CM values were significantly associated 
with xerostomia assessed with VAS (r=0.51, P<0.01), 
ESR (r=0.65, p<0.01) and the titre of ANA (r=0.5, 
P=0.01). No other statistically significant correlations 
were found between skin barrier tests and the rest of 
studied parameters; in particular the duration of the 
disease and the presence of ANA, including anti-SSA 
and anti-SSB antibodies, were not associated with cu-
taneous dryness measures.
DISCUSSION
The current report focuses on skin barrier function 
and hydration in patients with pSS and sSS. 
Despite a relatively high proportion of patients 
complaining of dry skin, we did not observe statisti-
cally significant differences in TEWL and CM between 
the SS group and healthy controls. This finding indi-
cates that complaints of dry skin observed in patients 
with SS are subjective rather than objective and is in 
agreement with the results of the study of Bernacchi 
et al. (3), who detected no pathological alterations 
in CM and evaporimetry in patients with pSS and 
demonstrated that xerosis in pSS is not a feature of 
chronic autoreactive lymphocytic exocrinopathy. 
Other pathophysiological hypotheses of skin dryness 
include neurologic conditions (i.e. neuropathy), fre-
quent in SS (6). However, as no patients underwent 
electrodiagnostic testing due to lack of clinical in-
dications, the results of the present study could not 
confirm or exclude neuropathy as a cause of the feel-
ing of dry skin in the investigated subjects. 
Moreover, our results point to a distinct pathoge-
netic mechanism of dry skin in patients with SS and AD. 
Xerosis is a specific component of AD and, in contrast to 
subjects with SS, we found reduced stratum corneum 
water content in the AD group. The observation was in 
agreement with a previous study, which showed that 
the skin of patients with AD lacks moisture (7). 
CONCLUSION
In conclusion, patients with pSS and sSS present 
no alterations in skin barrier function and hydration 
parameters.
ACKNOWLEDgEMENTS
We would like to thank Kamilla Klama, MD, PhD, 
from Ambulatory Individual Specialist Care, Prze-
myslowa, Poznan, Poland for help in patient recruit-
ment. 









Transepidermal water loss 
(g/m2/h)
9.1 (13.6) 7.2 (9.4) 13.7 (8.2) 9.8 (3.3)
Corneometry (U) 42.3 (24.5) 44.0 (16.8) 30.5 (15.8) 34.6 (11.9)
Data presented as the median (interquartile range); SS: Sjögren’s syndrome
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